Search results
Results from the WOW.Com Content Network
The 2009 initial funding, the 2010 initiation, the 2016 implementation, and ongoing operation of what would become the Phoenix pay system, was overseen by a series of the Department of Public Services and Procurement Canada Ministers, spanning the tenure of former-Prime Minister Harper (February 6, 2006 – November 4, 2015) and Prime Minister Justin Trudeau (2015–).
IQVIA, formerly Quintiles and IMS Health, Inc., [2] is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research.
During the 2017 tax year, the CRA collected approximately $430 billion in revenue on behalf of federal and provincial governments, and administered nearly $34 billion in benefits to Canadians. [7] The CRA is responsible to Parliament through the minister of national revenue (Marie Claude-Bibeau since 2023). The day-to-day operations of the ...
IMS Health v. Ayotte was a free speech case involving IMS Health. [28] [29] [30] Sorrell v. IMS Health Inc. was a case about physician-data privacy, which went to the U.S. Supreme Court., the High Court ruled in favor of the company. [31] [32] [33] [34]
A clinical research associate (CRA), also called a clinical monitor or trial monitor, is a health-care professional who performs many activities related to medical research, particularly clinical trials. Clinical research associates work in various settings, such as pharmaceutical companies, medical research institutes and government agencies.
The appeal process starts when a taxpayer formally objects to the CRA assessment, on prescribed form T400A. The objection must explain, in writing, the reasons for the appeal along with all the related facts. The objection is then reviewed by the appeals branch of the CRA. An appealed assessment may either be confirmed, vacated, or varied by ...
WASHINGTON (Reuters) -In its latest jab at Beijing, the U.S. will empower companies like Google and Microsoft to act as gatekeepers worldwide for highly sought-after access to AI chips, two people ...
In 1994, he took Quintiles public through an IPO. [6] Quintiles is the "largest global provider of clinical trials and commercial marketing services to the pharmaceutical and biotechnology industry". [5] In December 2015, Gillings retired as executive chairman of Quintiles, but remains a director. [6]